Gut microbiota and obesity

被引：0

作者：

Lonita-Radu, Florentina ^{[1
]}

Sirbu, Carmen A. ^{[2
]}

Docu-Axelerad, Any ^{[3
]}

Stefan, Ion ^{[4
,5
]}

机构：

[1] Carol Davila Univ Med & Pharm, Dept Internal Med & Gastroenterol, Bucharest, Romania

[2] Carol Davila Cent Mil Emergency Univ Hosp, Dept Neurol, Bucharest, Romania

[3] Ovidius Univ Constanta, Dept Neurol, Clin Emergency Hosp St Apostol Andrei, Dept 4,Fac Med, Constanta, Romania

[4] Titu Maiorescu Univ, Dept Med Surg & Prophylact Disciplines, Bucharest, Romania

[5] Carol Davila Univ Cent Emergency Mil Hosp, Dept Infect Dis, Bucharest, Romania

来源：

ROMANIAN JOURNAL OF MILITARY MEDICINE | 2022年 / 125卷 / 03期

关键词：

microbiota; diabetes; obesity; health problem; cancer; immune system; PLGA NANOPARTICLES; HYPERCALORIC DIET; CHILDHOOD OBESITY; VITAMIN-E; PROBIOTICS; LUTEIN; FAT;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Worldwide, adults and childhood obesity are increasing alarmingly, being a major health problem. Obesity is correlated with an increased incidence of various systemic diseases including cancer, heart diseases, and diabetes mellitus type 2. Risk factors for obesity are dysbiosis, genetic, socioeconomic, behavioural and environmental. The gut microbiota has beneficial effects on human health, like host immune system stimulation, being influenced by pH, or nutrient intake. Studies performed on humans and animal models reported differences regarding microbiota at lean and obese individuals. The consumption of probiotics and prebiotics may balance the microbiota with positive effects in obesity. The main aim of this review is to reveal the interaction between dysbiosis and obesity.

引用

页码：464 / 468

页数：5

共 62 条

[1]

Apovian CM, 2016, AM J MANAG CARE, V22

[2] Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders [J].

Aron-Wisnewsky, Judith ;

Vigliotti, Chloe ;

Witjes, Julia ;

Le, Phuong ;

Holleboom, Adriaan G. ;

Verheij, Joanne ;

Nieuwdorp, Max ;

Clement, Karine .

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (05) :279-297

[3] Dysbiosis and Prematurity: Is There a Role for Probiotics? [J].

Baldassarre, Maria Elisabetta ;

Di Mauro, Antonio ;

Capozza, Manuela ;

Rizzo, Valentina ;

Schettini, Federico ;

Panza, Raffaella ;

Laforgia, Nicola .

NUTRIENTS, 2019, 11 (06)

[4] GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN ANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS [J].

Barengolts, Elena .

ENDOCRINE PRACTICE, 2016, 22 (10) :1224-1234

[5]

Bibbò S, 2016, EUR REV MED PHARMACO, V20, P4742

[6] Probiotics and Covid-19 [J].

Bottari, Benedetta ;

Castellone, Vincenzo ;

Neviani, Erasmo .

INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2021, 72 (03) :293-299

[7] Humans against Obesity: Who Will Win? [J].

Caballero, Benjamin .

ADVANCES IN NUTRITION, 2019, 10 :S4-S9

[8] Phytochemicals That Influence Gut Microbiota as Prophylactics and for the Treatment of Obesity and Inflammatory Diseases [J].

Carrera-Quintanar, Lucrecia ;

Lopez Roa, Rocio I. ;

Quintero-Fabian, Saray ;

Sanchez-Sanchez, Marina A. ;

Vizmanos, Barbara ;

Ortuno-Sahagun, Daniel .

MEDIATORS OF INFLAMMATION, 2018, 2018

[9]

Casariu AE, 2013, FARMACIA, V61, P20

[10] Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives [J].

Catoi, Adriana Florinela ;

Vodnar, Dan Cristian ;

Corina, Andreea ;

Nikolic, Dragana ;

Citarrella, Roberto ;

Perez-Martinez, Pablo ;

Rizzo, Manfredi .

CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (18) :2038-2050

← 1 2 3 4 5 6 7 →